top of page

Thu, Apr 25

|

McCormick & Schmick's Seafood & Steaks

Nursing EMPOWER: Personalizing Patient Management through Communication and Education on Advanced Breast Cancer

Registration is Closed
See other events
Nursing EMPOWER: Personalizing Patient Management through Communication and Education on Advanced Breast Cancer
Nursing EMPOWER: Personalizing Patient Management through Communication and Education on Advanced Breast Cancer

Time & Location

Apr 25, 2019, 6:00 PM – 7:30 PM

McCormick & Schmick's Seafood & Steaks, 1 Faneuil Hall Market PL, Boston, MA 02109, USA

Guests

About The Event

LEARN MORE & REGISTER NOW @ https://www.medlearninggroup.com/cme-programming/bcon-ma2

We value your participation in this case-based CME/CNE Meeting, and we hope you will be able to join us. We welcome you to extend the invitation to your staff, colleagues, and anyone else you think would be interested in attending this exciting, new program. All from the medical community are welcome.

PROGRAM FEATURES

• No cost to attend

• Complimentary Dinner

• Online personalized nurse quality-improvement poster-generation portal

• Downloadable virtual and augmented reality animations

• Mobile responsive website/app

• Patient case videos

• Intra-activity patient or KNOW patient quizzing

• Reference toolkit

AVAILABLE CE Credits

1.5 AMA Category 1 Credits™

1.5 ANCC Contact Hour(s)

ONCC Recertification Points

PROGRAM CHAIR & PRESENTING FACULTY

Shayma Master Kazmi, M.D., R.Ph

Medical Lead of Advanced Oncology, Oncology/Hematology

Comprehensive Care and Research Center

Philadelphia, PA

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Describe the unique mechanism of action that CDK 4/6 inhibition provides as oral oncolytic agents in advanced or metastatic HR+/HER2-negative breast cancer

• Review the role of oral CDK 4/6 inhibitors in the treatment of advanced or metastatic breast cancer

• Explore the side-effect profiles of the CDK 4/6 inhibitors and toxicity management in the management of advanced or metastatic HR+/HER2-negative breast cancer

• Review the oncology nurse’s role in the recognition of breast cancer treatment-related adverse events while optimizing patient medication persistence

• Assess ways in which to communicate more openly with patients in order to encourage their engagement across all aspects of their care

• Evaluate current data for decision aids and shared decision-making in optimizing patient and healthcare-team communication and goal-setting

LEARN MORE & REGISTER NOW @ https://www.medlearninggroup.com/cme-programming/bcon-ma2

Share This Event

bottom of page